comparemela.com

Latest Breaking News On - மருத்துவ சோதனைகள் ஆஂடேரியொ - Page 1 : comparemela.com

NeonMind CEO Provides Update on the Progress of its Psilocybin Drug Development Research Plan and Team

NeonMind CEO Provides Update on the Progress of its Psilocybin Drug Development Research Plan and Team
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

NeonMind Biosciences Inc: NeonMind CEO Provides Update on the Progress of its Psilocybin Drug Development Research Plan and Team

NeonMind Biosciences Inc: NeonMind CEO Provides Update on the Progress of its Psilocybin Drug Development Research Plan and Team
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Edesa Biotech to Join Panel Discussion at Government COVID-19 Event

Edesa Biotech to Join Panel Discussion at Government COVID-19 Event TORONTO, ON / ACCESSWIRE / January 20, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, announced today that Dr. Par Nijhawan, Chief Executive Officer, is scheduled to participate in a virtual event organized by Clinical Trials Ontario in collaboration with the Bureau du Québec à Toronto and the Canadian and International Innovation Partnerships Directorate. As part of a government and industry panel, Dr. Nijhawan is expected to discuss the importance of developing multiple countermeasures to the COVID-19 pandemic, including therapies, like Edesa s EB05 drug candidate, that target the overactive host immune response in COVID-19 patients.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.